Bangladesh
· Delayed Price · Currency is BDT Pharma Aids Statistics
Total Valuation
Pharma Aids has a market cap or net worth of BDT 1.62 billion. The enterprise value is 1.60 billion.
| Market Cap | 1.62B |
| Enterprise Value | 1.60B |
Important Dates
The next estimated earnings date is Thursday, January 29, 2026.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | Dec 8, 2025 |
Share Statistics
Pharma Aids has 3.12 million shares outstanding.
| Current Share Class | 3.12M |
| Shares Outstanding | 3.12M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 23.99.
| PE Ratio | 23.99 |
| Forward PE | n/a |
| PS Ratio | 3.57 |
| PB Ratio | 3.57 |
| P/TBV Ratio | 3.57 |
| P/FCF Ratio | 189.14 |
| P/OCF Ratio | 24.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.49, with an EV/FCF ratio of 186.94.
| EV / Earnings | 23.71 |
| EV / Sales | 3.52 |
| EV / EBITDA | 16.49 |
| EV / EBIT | 17.79 |
| EV / FCF | 186.94 |
Financial Position
The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.03 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.21 |
| Debt / FCF | 2.43 |
| Interest Coverage | 38.45 |
Financial Efficiency
Return on equity (ROE) is 16.56% and return on invested capital (ROIC) is 13.14%.
| Return on Equity (ROE) | 16.56% |
| Return on Assets (ROA) | 10.04% |
| Return on Invested Capital (ROIC) | 13.14% |
| Return on Capital Employed (ROCE) | 19.70% |
| Revenue Per Employee | 4.82M |
| Profits Per Employee | 716,998 |
| Employee Count | 94 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 4.42 |
Taxes
In the past 12 months, Pharma Aids has paid 20.30 million in taxes.
| Income Tax | 20.30M |
| Effective Tax Rate | 23.15% |
Stock Price Statistics
The stock price has decreased by -12.12% in the last 52 weeks. The beta is -0.09, so Pharma Aids's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | -12.12% |
| 50-Day Moving Average | 541.98 |
| 200-Day Moving Average | 550.10 |
| Relative Strength Index (RSI) | 44.56 |
| Average Volume (20 Days) | 11,839 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharma Aids had revenue of BDT 453.49 million and earned 67.40 million in profits. Earnings per share was 21.60.
| Revenue | 453.49M |
| Gross Profit | 139.00M |
| Operating Income | 89.83M |
| Pretax Income | 87.70M |
| Net Income | 67.40M |
| EBITDA | 96.90M |
| EBIT | 89.83M |
| Earnings Per Share (EPS) | 21.60 |
Balance Sheet
The company has 39.55 million in cash and 20.75 million in debt, giving a net cash position of 18.81 million or 6.03 per share.
| Cash & Cash Equivalents | 39.55M |
| Total Debt | 20.75M |
| Net Cash | 18.81M |
| Net Cash Per Share | 6.03 |
| Equity (Book Value) | 453.40M |
| Book Value Per Share | 145.32 |
| Working Capital | 310.21M |
Cash Flow
In the last 12 months, operating cash flow was 66.08 million and capital expenditures -57.53 million, giving a free cash flow of 8.55 million.
| Operating Cash Flow | 66.08M |
| Capital Expenditures | -57.53M |
| Free Cash Flow | 8.55M |
| FCF Per Share | 2.74 |
Margins
Gross margin is 30.65%, with operating and profit margins of 19.81% and 14.86%.
| Gross Margin | 30.65% |
| Operating Margin | 19.81% |
| Pretax Margin | 19.34% |
| Profit Margin | 14.86% |
| EBITDA Margin | 21.37% |
| EBIT Margin | 19.81% |
| FCF Margin | 1.89% |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.58%.
| Dividend Per Share | 3.00 |
| Dividend Yield | 0.58% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 11.37% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.58% |
| Earnings Yield | 4.17% |
| FCF Yield | 0.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.
| Last Split Date | Dec 4, 2011 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
Pharma Aids has an Altman Z-Score of 9.56 and a Piotroski F-Score of 4.
| Altman Z-Score | 9.56 |
| Piotroski F-Score | 4 |